Intervention Review

You have free access to this content

Corticosteroids for tuberculous pleurisy

  1. Mark E Engel1,*,
  2. Patrice T Matchaba2,
  3. Jimmy Volmink3

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 23 JUL 2007

DOI: 10.1002/14651858.CD001876.pub2

How to Cite

Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD001876. DOI: 10.1002/14651858.CD001876.pub2.

Author Information

  1. 1

    Faculty of Health Sciences, University of Cape Town, Department of Medicine, Observatory, South Africa

  2. 2

    Novartis Pharmaceuticals Corporation, East Hanover, USA

  3. 3

    University of Stellenbosch, Faculty of Health Sciences, Tygerberg, South Africa

*Mark E Engel, Department of Medicine, Faculty of Health Sciences, University of Cape Town, J47 Old Main Building, Groote Schuur Hospital, Observatory, 7925, South Africa. mark.engel@mrc.ac.za.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Bang 1997 {published data only}
  • Bang JS, Kim MS, Kwak SM, Cho CH. Evaluation of steroid therapy in tuberculous pleurisy - A prospective, randomized study. Tuberculosis and Respiratory Disease 1997;44(1):52-8.
Elliott 2004 {published and unpublished data}
  • Elliott AM, Luzze H, Quigley MA, Nakiyingi J, Kyaligonza S, Namujju PB, et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. Journal of Infectious Diseases 2004;190(5):869-78.
Galarza 1995 {published data only}
Lee 1988 {published data only}
Lee 1999 {published data only}
  • Lee BH, Jee HS, Choi JC, Park YB, An CH, Kim JY, et al. Therapeutic effect of prednisolone in tuberculous pleurisy - A prospective study for the prevention of the pleural adhesion. Tuberculosis and Respiratory Disease 1999;46(4):481-8.
Wyser 1996 {published data only}
  • Wyser C, Walzl G, Smedema JP, Swart F, van Schalkwyk EM, van de Wal BW. Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 1996;110(2):333-8.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Aspin 1958 {published data only}
Bilaceroglu 1999 {published data only}
  • Bilaceroglu S, Perim K, Buyuksirin M, Celikten E. Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial. International Journal of Tuberculosis and Lung Disease 1999;3(1):47-54.
Cherednikova 1973 {published data only}
  • Cherednikova GV. Immediate and late results of treatment with corticosteroid hormones of children with tuberculosis [Blizhaishie i otdalennye rezul'taty lecheniia kortikosteroidnymi gormonami detei, bol'nykh tuberkulezom]. Problemy Tuberkuleza 1973;51(12):46-9.
Cisneros 1996 {published data only}
Damany 1968 {published data only}
  • Damany SJ, Shah KT. Treatment of pleural effusion with and without triamcinolone in addition to usual antituberculosis chemotherapy. Journal of the Indian Medical Association 1968;51(8):391-3.
Filler 1963 {published data only}
  • Filler J, Porter M. Physiologic studies of the sequelae of tuberculous pleural effusion in children treated with antimicrobial drugs and prednisone. American Review of Respiratory Disease 1963;88:181-8.
Fleishman 1960 {published data only}
  • Fleishman SI, Coetzee AM, Mindel S, Berjak J, Lichter AI. Antituberculous therapy combined with adrenal steroids in the treatment of pleural effusions: a controlled therapeutic trial. Lancet 1960;23(1):199-201.
Grewal 1969 {published data only}
  • Grewal KS, Dixit RP, Sil DR. A comparative study of therapeutic regimens with and without corticosteroids in the treatment of tuberculous pleural effusion. Journal of the Indian Medical Association 1969;52(11):514-6.
Khomenko 1990 {published data only}
  • Khomenko IS, Chukanov VI, Gergert VI, Utkin VV. Effectiveness of antitubercular chemotherapy combined with corticosteroids and immunomodulators [Effektivnost' protivotuberkuleznoi khimioterapii v sochetanii s kortikosteroidami i immunomoduliatorami]. Problemy Tuberkuleza 1990;1:24-8.
Manresa 1997 {published data only}
Mathur 1960 {published data only}
  • Mathur KS, Prasad R, Mathur JS. Intrapleural hydrocortisone in tuberculous pleural effusion. Tubercle 1960;41:358-62.
Mathur 1965 {published data only}
  • Mathur KS, Mathur JS, Sapru RP. Treatment of tuberculosis pleural effusion with local instillation of hydrocortisone. Diseases of the Chest 1965;47:303-9.
Mayanja-Kizza 2005 {published data only}
  • Mayanja-Kizza H, Jones-Lopez E, Okwera A, Wallis R, Ellner J, Mugerwa R, Whalen C, for the Uganda-Case Western Research Collaboration. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. Journal of Infectious Diseases 2005;191(6):856-65.
Menon 1964 {published data only}
  • Menon NK. Steroid therapy in tuberculous effusion. Tubercle 1964;45:17-20.
Paheco 1973 {published data only}
  • Pacheco CR, Valdez-Ochoa S, Naranjo F, Alvarez H, Aguilar M, Saavedra M. Clinical study of a new synthetic steroid in the treatment of pleural tuberculosis [Estudio clinico de un nuevo esteroide de sintesis en el tratamiento de la pleuresia tuberculosa]. Gaceta Medica de Mexico 1973;106(3):249-55.
Paley 1959 {published data only}
  • Paley SS, Mihaly JP, Mais EL, Gittens SA, Lupini B. Prednisolone in the treatment of tuberculous pleural effusions. American Review of Tuberculosis 1959;79:307-14.
Porsio 1966 {published data only}
  • Porsio A, Borgia M. Controlled clinical trials of the use of a new anabolic agent in a Sanatorium. La Clinica Terapeutica 1966;37(6):502-18.
Singh 1965 {published data only}
  • Singh D, Yesikar SS. Role of intrapleural corticosteroids in tuberculous pleural effusion: a clinicotherapeutic trial of 50 cases. Journal of the Indian Medical Association 1965;45(6):306-9.
Starostenko 1989 {published data only}
  • Starostenko EV, Novoselova VP. Indications for the use of prednisolone in tuberculosis. Problemy Tuberkuleza 1989;1:44-7.
Tani 1964 {published data only}
  • Tani P, Poppius H, Makipaja J. Cortisone therapy for exudative tuberculous pleurisy in the light of a follow-up study. Acta Tuberculosea Scandinavica 1964;44:303-9.
Tanzj 1965 {published data only}
  • Tanzj PL, Andreini E. On therapeutic use of corticosteroids in pleuro-pulmonary tuberculosis. Archivio di Tisiologia e delle Malattie dell'Apparato Respiratorio 1965;20(5):331-57.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Anonymous 1983
  • Anonymous. Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India. Tubercle 1983;64(2):73-91.
Batungwanayo 1993
Blumberg 2003
  • Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. American Journal of Respiratory and Critical Care Medicine 2003;167(4):603-62.
Chapman 2004
Commerford 1991
  • Commerford PJ, Strang JIG. Tuberculous pericarditis. In: Coovadia HM, Benatar SR editor(s). A century of tuberculosis: South African perspectives. Cape Town: Oxford University Press, 1991:123-36.
Dooley 1997
Elliott 1992
  • Elliott AM, Halwiindi B, Bagshawe A, Hayes RJ, Luo N, Pobee JO, et al. Use of prednisolone in the treatment of HIV-positive tuberculosis patients. Quarterly Journal of Medicine 1992;85(307-8):855-60.
Ensoli 2001
Frye 1997
Harries 1990
Higgins 2006
  • Higgins JPT, Green S. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 1 May 2007).
Jüni 2001
Lemaistre 1951
  • Lemaistre CA, Tompsett R, Muschenheim C, Moore JA, McDermott W. Effects of adrenocorticotropic hormone and cortisone in patients with tuberculosis. Journal of Clinical Investigation 1951;30(5):445-56.
Lionakis 2003
McAllister 1983
Morehead 1998
Relkin 1994
Review Manager 5
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Rossi 1987
  • Rossi GA, Balbi B, Manca F. Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. American Review of Respiratory Disease 1987;136(3):575-9.
Seibert 1991
Sharma 2004
Song 2003
  • Song AT, Schout D, Novaes HM, Goldbaum M. Clinical and epidemiological features of AIDS/tuberculosis comorbidity. Revista do Hospital das Clinicas 2003;58(4):207-14.
WHO 2005
  • World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2005 [WHO/HTM/TB/2005.349]. Geneva: World Health Organization, 2005.
Yang 2004

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Matchaba 2000